{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:24:05Z","timestamp":1788906245070,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T00:00:00Z","timestamp":1555459200000},"content-version":"am","delay-in-days":351,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP17am0101098"],"award-info":[{"award-number":["JP17am0101098"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP17dm0207001"],"award-info":[{"award-number":["JP17dm0207001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["J2015571"],"award-info":[{"award-number":["J2015571"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP16K01956"],"award-info":[{"award-number":["JP16K01956"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP16H01493"],"award-info":[{"award-number":["JP16H01493"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP25293254"],"award-info":[{"award-number":["JP25293254"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Analytical Biochemistry"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ab.2018.04.001","type":"journal-article","created":{"date-parts":[[2018,4,5]],"date-time":"2018-04-05T22:48:47Z","timestamp":1522968527000},"page":"174-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Quantification of receptor activation by oxytocin and vasopressin in endocytosis-coupled bioluminescence reduction assay using nanoKAZ"],"prefix":"10.1016","volume":"549","author":[{"given":"Isao","family":"Kii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shino","family":"Hirahara-Owada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Niwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Koike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Sonamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harumi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayo","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihiro","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamitsu","family":"Hosoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyoshi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ab.2018.04.001_bib1","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.neuron.2010.03.005","article-title":"The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior","volume":"65","author":"Insel","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.ab.2018.04.001_bib2","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/jne.12154","article-title":"Oxytocin: its mechanism of action and receptor signalling in the myometrium","volume":"26","author":"Arrowsmith","year":"2014","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.ab.2018.04.001_bib3","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nrn3044","article-title":"Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine","volume":"12","author":"Meyer-Lindenberg","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ab.2018.04.001_bib4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s40272-017-0248-y","article-title":"A review of the safety, efficacy and mechanisms of delivery of nasal oxytocin in children: therapeutic potential for autism and prader-willi syndrome, and recommendations for future research","volume":"19","author":"DeMayo","year":"2017","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.ab.2018.04.001_bib5","article-title":"Systematic review and meta-analysis of reported adverse events of long-term intranasal oxytocin treatment for autism spectrum disorder","author":"Cai","year":"2017","journal-title":"Psychiatr. Clin. Neurosci."},{"issue":"92","key":"10.1016\/j.ab.2018.04.001_bib6","article-title":"The effect of oxytocin on attention to angry and happy faces in chronic depression","volume":"16","author":"Domes","year":"2016","journal-title":"BMC Psychiatr."},{"key":"10.1016\/j.ab.2018.04.001_bib7","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s10578-016-0642-7","article-title":"The effects of intranasal oxytocin administration on sensitive caregiving in mothers with postnatal depression","volume":"48","author":"Mah","year":"2017","journal-title":"Child Psychiatr. Hum. Dev."},{"key":"10.1016\/j.ab.2018.04.001_bib8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.biopsych.2015.06.004","article-title":"Oxytocin in general anxiety and social fear: a translational approach","volume":"79","author":"Neumann","year":"2016","journal-title":"Biol. Psychiatr."},{"issue":"1\u201350","key":"10.1016\/j.ab.2018.04.001_bib9","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S1054-3589(04)50016-9","article-title":"General introduction to vasopressin and oxytocin: structure\/metabolism, evolutionary aspects, neural pathway\/receptor distribution, and functional aspects relevant to memory processing","volume":"50","author":"McEwen","year":"2004","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.ab.2018.04.001_bib10","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1590\/1678-4685-gmb-2015-0323","article-title":"Oxytocin and arginine vasopressin receptor evolution: implications for adaptive novelties in placental mammals","volume":"39","author":"Pare","year":"2016","journal-title":"Genet. Mol. Biol."},{"key":"10.1016\/j.ab.2018.04.001_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1146\/annurev-med-050913-022838","article-title":"Vasopressin receptor antagonists, heart failure, and polycystic kidney disease","volume":"66","author":"Torres","year":"2015","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ab.2018.04.001_bib12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1517\/14728222.10.3.423","article-title":"Targeting the oxytocin receptor to relax the myometrium","volume":"10","author":"Akerlund","year":"2006","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ab.2018.04.001_bib13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0079-6123(08)00437-8","article-title":"Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents","volume":"170","author":"Manning","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.ab.2018.04.001_bib14","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1124\/jpet.113.202994","article-title":"Selective and potent agonists and antagonists for investigating the role of mouse oxytocin receptors","volume":"346","author":"Busnelli","year":"2013","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ab.2018.04.001_bib15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1530\/jrf.0.1010345","article-title":"Antagonists for the human oxytocin receptor: an in vitro study","volume":"101","author":"Maggi","year":"1994","journal-title":"J. Reprod. Fertil."},{"key":"10.1016\/j.ab.2018.04.001_bib16","article-title":"Cross-talk among oxytocin and arginine-vasopressin receptors: relevance for basic and clinical studies of the brain and periphery","author":"Song","year":"2017","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.ab.2018.04.001_bib17","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1080\/13543776.2017.1379992","article-title":"A patent review of oxytocin receptor antagonists 2013-2017","volume":"27","author":"Katte","year":"2017","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ab.2018.04.001_bib18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1517\/13543776.2014.845168","article-title":"Novel oxytocin receptor agonists and antagonists: a patent review (2002-2013)","volume":"24","author":"Yang","year":"2014","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ab.2018.04.001_bib19","doi-asserted-by":"crossref","first-page":"5242","DOI":"10.1016\/j.bmcl.2008.08.066","article-title":"Triazole oxytocin antagonists: identification of aryl ether replacements for a biaryl substituent","volume":"18","author":"Brown","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ab.2018.04.001_bib20","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1016\/j.bmcl.2008.06.098","article-title":"Design and optimization of potent, selective antagonists of oxytocin","volume":"18","author":"Brown","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ab.2018.04.001_bib21","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.bmcl.2009.11.097","article-title":"Triazole oxytocin antagonists: identification of an aryloxyazetidine replacement for a biaryl substituent","volume":"20","author":"Brown","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ab.2018.04.001_bib22","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.bmcl.2010.01.143","article-title":"Identification of a urea bioisostere of a triazole oxytocin antagonist","volume":"20","author":"Brown","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ab.2018.04.001_bib23","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.copbio.2005.10.008","article-title":"Functional assays for screening GPCR targets","volume":"16","author":"Thomsen","year":"2005","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.ab.2018.04.001_bib24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/bs.mcb.2015.11.001","article-title":"Tango assay for ligand-induced GPCR-beta-arrestin2 interaction: application in drug discovery","volume":"132","author":"Dogra","year":"2016","journal-title":"Meth. Cell Biol."},{"key":"10.1016\/j.ab.2018.04.001_bib25","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/aps.2011.173","article-title":"Tools for GPCR drug discovery","volume":"33","author":"Zhang","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ab.2018.04.001_bib26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0076-6879(06)14008-2","article-title":"G protein-coupled receptor internalization assays in the high-content screening format","volume":"414","author":"Haasen","year":"2006","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ab.2018.04.001_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cellsig.2017.01.024","article-title":"GPCR desensitization: acute and prolonged phases","volume":"41","author":"Rajagopal","year":"2018","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ab.2018.04.001_bib28","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.bbamem.2014.11.026","article-title":"Quantitative measurement of cell membrane receptor internalization by the nanoluciferase reporter: using the G protein-coupled receptor RXFP3 as a model","volume":"1848","author":"Liu","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ab.2018.04.001_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ab.2015.08.005","article-title":"A luminescent assay for real-time measurements of receptor endocytosis in living cells","volume":"489","author":"Robers","year":"2015","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ab.2018.04.001_bib30","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1021\/cb3002478","article-title":"Engineered luciferase reporter from a deep sea shrimp utilizing a novel imidazopyrazinone substrate","volume":"7","author":"Hall","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ab.2018.04.001_bib31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bbrc.2013.06.026","article-title":"C6-Deoxy coelenterazine analogues as an efficient substrate for glow luminescence reaction of nanoKAZ: the mutated catalytic 19 kDa component of Oplophorus luciferase","volume":"437","author":"Inouye","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ab.2018.04.001_bib32","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bbrc.2015.12.123","article-title":"Crystal structure of nanoKAZ: the mutated 19 kDa component of Oplophorus luciferase catalyzing the bioluminescent reaction with coelenterazine","volume":"470","author":"Tomabechi","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ab.2018.04.001_bib33","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1021\/jm010526+","article-title":"Synthesis and characterization of fluorescent antagonists and agonists for human oxytocin and vasopressin V(1)(a) receptors","volume":"45","author":"Terrillon","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ab.2018.04.001_bib34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbrc.2014.01.133","article-title":"Luminescence enhancement of the catalytic 19 kDa protein (KAZ) of Oplophorus luciferase by three amino acid substitutions","volume":"445","author":"Inouye","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ab.2018.04.001_bib35","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1046\/j.1432-1327.1999.00892.x","article-title":"Structural requirements for V2 vasopressin receptor proteolytic cleavage","volume":"266","author":"Kojro","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ab.2018.04.001_bib36","doi-asserted-by":"crossref","first-page":"6034","DOI":"10.1021\/ac8008548","article-title":"Phosphorylation analysis of G protein-coupled receptor by mass spectrometry: identification of a phosphorylation site in V2 vasopressin receptor","volume":"80","author":"Wu","year":"2008","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ab.2018.04.001_bib37","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1039\/c3sc51985f","article-title":"Development of cell-impermeable coelenterazine derivatives","volume":"4","author":"Lindberg","year":"2013","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ab.2018.04.001_bib38","doi-asserted-by":"crossref","first-page":"17158","DOI":"10.1002\/chem.201501531","article-title":"Synthetic routes to coelenterazine and other imidazo[1,2-a]pyrazin-3-one luciferins: essential tools for bioluminescence-based investigations","volume":"21","author":"Coutant","year":"2015","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ab.2018.04.001_bib39","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1021\/acs.orglett.5b01872","article-title":"Concise synthesis of v-coelenterazines","volume":"17","author":"Hosoya","year":"2015","journal-title":"Org. Lett."},{"key":"10.1016\/j.ab.2018.04.001_bib40","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ab.2010.08.025","article-title":"Application of new semisynthetic aequorins with long half-decay time of luminescence to G-protein-coupled receptor assay","volume":"407","author":"Inouye","year":"2010","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ab.2018.04.001_bib41","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.pep.2012.12.006","article-title":"Expression, purification and luminescence properties of coelenterazine-utilizing luciferases from Renilla, Oplophorus and Gaussia: comparison of substrate specificity for C2-modified coelenterazines","volume":"88","author":"Inouye","year":"2013","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.ab.2018.04.001_bib42","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1039\/C4CC06886F","article-title":"Bioluminescent coelenterazine derivatives with imidazopyrazinone C-6 extended substitution","volume":"51","author":"Nishihara","year":"2015","journal-title":"Chem. Commun. (J. Chem. Soc. Sect. D)"},{"key":"10.1016\/j.ab.2018.04.001_bib43","doi-asserted-by":"crossref","first-page":"10369","DOI":"10.1002\/chem.201601111","article-title":"Three efficient methods for preparation of coelenterazine analogues","volume":"22","author":"Shakhmin","year":"2016","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ab.2018.04.001_bib44","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/978-3-319-41523-9_5","article-title":"Control of adhesion GPCR function through proteolytic processing","volume":"234","author":"Nieberler","year":"2016","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.ab.2018.04.001_bib45","doi-asserted-by":"crossref","first-page":"43933","DOI":"10.1074\/jbc.M208407200","article-title":"The extracellular N terminus of the endothelin B (ETB) receptor is cleaved by a metalloprotease in an agonist-dependent process","volume":"277","author":"Grantcharova","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ab.2018.04.001_bib46","doi-asserted-by":"crossref","first-page":"7890","DOI":"10.1038\/s41598-017-06607-z","article-title":"beta1-adrenergic receptor O-glycosylation regulates N-terminal cleavage and signaling responses in cardiomyocytes","volume":"7","author":"Park","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ab.2018.04.001_bib47","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1074\/jbc.M116.730614","article-title":"Site-specific O-Glycosylation by polypeptide N-Acetylgalactosaminyltransferase 2 (GalNAc-transferase T2) Co-regulates beta1-adrenergic receptor N-terminal cleavage","volume":"292","author":"Goth","year":"2017","journal-title":"J. Biol. Chem."}],"container-title":["Analytical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269718302380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269718302380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T11:58:13Z","timestamp":1762084693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003269718302380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":47,"alternative-id":["S0003269718302380"],"URL":"https:\/\/doi.org\/10.1016\/j.ab.2018.04.001","relation":{},"ISSN":["0003-2697"],"issn-type":[{"value":"0003-2697","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantification of receptor activation by oxytocin and vasopressin in endocytosis-coupled bioluminescence reduction assay using nanoKAZ","name":"articletitle","label":"Article Title"},{"value":"Analytical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ab.2018.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}